Cara Therapeutics
Patents, Design & Utilities

Last updated:

List of all Cara Therapeutics patents 7 in total

Status Patent
Application
Utility: Oral Formulations of Kappa Opioid Receptor Agonists External link
Filling date: 6 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS External link
Filling date: 6 Sep 2025 Issue date: 23 Sep 2021
Grant
Utility: Oral formulations of kappa opioid receptor agonists External link
Filling date: 6 Sep 2025 Issue date: 15 Jun 2021
Grant
Utility: Synthetic peptide amides and dimers thereof External link
Filling date: 6 Sep 2025 Issue date: 9 Feb 2021
Grant
Utility: Synthetic peptide amides External link
Filling date: 6 Sep 2025 Issue date: 6 Oct 2020
Application
Utility: Oral Formulations of Kappa Opioid Receptor Agonists External link
Filling date: 6 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: SYNTHETIC PEPTIDE AMIDES External link
Filling date: 6 Sep 2025 Issue date: 8 Aug 2019

Showing 1 to 7 of 7 patents.